The anti-HCV rapid test is a point-of-care immunoassay that detects antibodies to hepatitis C virus in blood (fingerstick, serum, or plasma) and delivers results within minutes. It’s used for initial screening in clinics, outreach, and emergency settings. A reactive result suggests past or current infection but always requires confirmatory HCV RNA testing; very recent infections can be missed during the antibody window period.

A positive anti-HCV (hepatitis C antibody) test means you've been exposed to hepatitis C. It does not prove active infection — an HCV RNA (PCR) test is needed to confirm current virus. If RNA positive, assess liver health, check genotype/degree of fibrosis, vaccinate against A and B if needed, counsel on transmission, and refer for antiviral treatment, which cures most people.

Anti-HCV (hepatitis C antibody) test prices vary widely: many public health services and community clinics offer it free or low-cost. In India private labs typically charge around ₹300–₹800. In the United States out‑of‑pocket costs commonly range from about $20–$150 (lab or clinic dependent); insured patients often pay little or nothing. Confirmatory RNA testing costs more.

No — an anti‑HCV (hepatitis C antibody) blood test does not require fasting. You can eat and drink normally before the test. Follow any specific instructions from your clinic or lab, since they may also order other blood tests with different requirements. Tell staff about recent vaccinations, illnesses, or medications that could affect results.

Hepatitis C is now curable in most people using direct-acting antiviral (DAA) drugs taken for 8–12 weeks; cure is defined by an undetectable viral load 12 weeks after finishing treatment (SVR), with cure rates above 90–95%. Treatment is recommended for nearly everyone. However, existing liver scarring may not fully reverse and needs ongoing monitoring and care.

“Reactive” on a lab report generally means the test detected a response and is treated like a positive result. However, it doesn’t always prove active infection; it can reflect past exposure, vaccination, cross‑reactivity, or a false positive. Most reactive results require confirmatory testing and clinical correlation before definitive diagnosis or treatment decisions are made.